Cargando…
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
Immunotherapy has become a key therapeutic strategy in the treatment of many cancers. As a result, research efforts have been aimed at understanding mechanisms of resistance to immunotherapy and how anti-tumor immune response can be therapeutically enhanced. It has been shown that tumor cell recogni...
Autores principales: | Taylor, Brandie C., Balko, Justin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920040/ https://www.ncbi.nlm.nih.gov/pubmed/35296095 http://dx.doi.org/10.3389/fimmu.2022.844866 |
Ejemplares similares
-
Downregulation of MHC Class I Expression by Influenza A and B Viruses
por: Koutsakos, Marios, et al.
Publicado: (2019) -
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
por: Cornel, Annelisa M., et al.
Publicado: (2020) -
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
por: Romero, Irene, et al.
Publicado: (2018) -
Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium
por: Gopalakrishnan, Shreya, et al.
Publicado: (2022) -
The Role of Insulin-Regulated Aminopeptidase in MHC Class I Antigen Presentation
por: Saveanu, Loredana, et al.
Publicado: (2012)